Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 11 September 2024, 10:42 HKT/SGT
Share:
    

Source: TR Capital
TR Capital Announces Appointment of Fourth Partner in Drive for Accelerated Growth

- Deepanshu Madan, an Indian national with experience across India and Southeast Asia, becomes the latest partner at Asia’s leading secondary private equity firm

- TR’s India business continues to expand and to capture growing opportunities as one of the first-movers in this space

Singapore and Mumbai, Sept 11, 2024 - (ACN Newswire) - TR Capital, the leading Asian secondary private equity firm, is pleased to announce that Deepanshu Madan has been made the firm’s fourth Partner, marking an important milestone in the firm’s strategic growth.

Deepanshu joined TR Capital seven years ago as a Director, and has since played a pivotal role in the development of the firm’s retail and healthcare portfolio across Asia. In November 2023, he was appointed as the Chief Executive Officer of one of the firm’s portfolio companies, Pharmacity, in Vietnam. At Pharmacity, he is implementing a thorough redesign of the business model to return it to sustainable profitability.

Paul Robine, Founder and CEO of TR Capital, said, “I am thrilled to welcome Deepanshu as our fourth Partner. His exemplary track record over the past seven years, including his exceptional contributions at Pharmacity, underscores the effectiveness of TR’s active investment approach.”

Deepanshu Madan, Partner at TR Capital, said, “I am pleased to be appointed as a Partner at TR Capital and to contribute to the strong investment and ownership culture at the firm. We will continue to push boundaries in developing and supporting our portfolio companies whilst delivering on our active investment approach.”

This new addition to TR Capital’s senior leadership team is a strategic move to bolster the firm’s expansion in key markets, particularly in India. Recent initiatives, including leading the innovative Samara Capital continuation fund and the Fibe secondary direct deal, highlight TR's commitment to advancing its market presence.

In accordance with its growth strategy, TR Capital has recently realigned its local teams at the Director and VP levels to ensure it remains attuned to the dynamics of each local market.

Mr. Robine further commented, “The global secondary market landscape is evolving rapidly, particularly in India, where smaller secondary funds are surfacing alongside established players like TR Capital, creating an increasingly dynamic industry. As a pioneer in this sector, we take great pride in our innovative contributions to the Indian market and look forward to continued success in the future.”

About TR Capital

TR Capital is a leading secondary private equity investor in the Asia-Pacific region, providing liquidity solutions to owners of private equity assets through single asset and portfolio transactions. 

The firm makes significant investments in innovative leaders in the Technology, Next-Generation Consumer and Healthcare sectors across Asia. TR Capital is an active investor and shareholder and works with its portfolio companies to optimize their business models and capital structures. 

TR Capital currently manages funds with aggregate capital commitments of close to US$1.5 billion. The firm’s sophisticated investor base includes sovereign funds, pension funds, asset management firms, entrepreneurs, and family offices.

For more information, please contact:

Artemis Associates

Diana Footitt, CEO

diana.footitt@artemisassociates.com

+852 9183 0667

Dan Bradley, Managing Director

dan.bradley@artemisassociates.com

+852 6145 7455

Bowen Chui, Director

bowen.chui@artemisassociates.com

+852 9783 0643

 




Topic: Press release summary
Source: TR Capital

Sectors: Funds & Equities
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
TINGYI (CAYMAN ISLANDS) HOLDING CORP. Business Momentum Sustained in 2025, United for a New Journey, with GPM Rising to 34.8%, Profit Attributable to Shareholders Up 20.5% YoY  
Mar 24, 2026 10:31 HKT/SGT
International Career Institute Marks 20 Years with 100 Scholarships to Support Flexible Online Study  
Mar 24, 2026 07:29 HKT/SGT
Doubleview Gold Clarifies Preliminary Economic Assessment Results for the Hat Project; Updated Scenario B NPV Increased to C$7.27 Billion  
Mar 24, 2026 04:59 HKT/SGT
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries  
Mar 23, 2026 23:15 HKT/SGT
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders  
Mar 23, 2026 21:05 HKT/SGT
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share  
Mar 23, 2026 20:51 HKT/SGT
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe  
Mar 23, 2026 20:29 HKT/SGT
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint  
Mar 23, 2026 18:59 HKT/SGT
From SGD to Global Spending: How Singaporeans Can Avoid FX Fees While Travelling Overseas  
Mar 23, 2026 14:15 HKT/SGT
Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning  
Monday, March 23, 2026 1:24:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: